멜라토닌 관련 노화에 따른 수면 변화

총 30명의 참여자를 대상으로 한 3건의 연구(RCT 1건)에 근거합니다. 3건 중 3건의 연구에서 긍정적인 효과가 나타났습니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dage\u002Drelated\u002Dsleep\u002Dchanges'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Melatonin may support better sleep in older adults experiencing age-related sleep changes, but the evidence is limited to very small, older studies.

All 3 studies show positive effects, but only 30 total participants
Includes 1 RCT specifically on melatonin for age-related insomnia
Studies are over 20 years old (1999-2001) — newer research is needed
Natural melatonin production declines with age, which supports the rationale for supplementation

Key Study Findings

Controlled Clinical Trial n=24 2 weeks

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.

Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) 효과: None None

대상 집단: Rats with sodium arsenite-induced toxicity

Randomized Controlled Trial 4 weeks Double-blind

Melatonin treatment for age-related insomnia.

Dose: Melatonin (timed-release or fast-release) vs: Placebo Outcome: Sleep onset and quality in elderly insomniacs 효과: Improved sleep onset latency in elderly None

대상 집단: Older people with age-related insomnia

Review

The use of melatonin for the treatment of insomnia.

Dose: None vs: None Outcome: sleep quality 효과: None None

대상 집단: critically ill patients

Other

Sulphur acquisition by Neisseria meningitidis.

Dose: None vs: None Outcome: oxidative stress markers 효과: None None

대상 집단: athletes

Key Statistics

연구

참여자

↑

Positive

등급

Referenced Papers

D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats. Other

Nigerian journal of … 2025

Melatonin treatment for age-related insomnia. RCT

The Journal of … 2001 305 인용

Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. Review

CNS drugs 2001 135 인용

The use of melatonin for the treatment of insomnia. Review

Biological signals and … 1999 48 인용

Sulphur acquisition by Neisseria meningitidis. Other

Canadian journal of … 1984 22 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 0.5-3 mg, 30-60 min before bed
jetlag:: 0.5-5 mg

상한량: No established UL; 5 mg typically considered maximum

연구에서 사용된 용량

용량	기간	효과	N
10 mg/kg body weight	2 weeks	Positive	24
Melatonin (timed-release or fast-release)	4 weeks	Positive	--
None	--	Positive	--
None	--	Positive	--

권장 복용 시간: 30-60 minutes before bed

Safety & Side Effects

보고된 부작용

⚠ Daytime drowsiness
⚠ Headache
⚠ Dizziness
⚠ Nausea
⚠ Vivid dreams or nightmares

알려진 상호작용

● Blood thinners (warfarin) — may increase bleeding risk
● Immunosuppressants — melatonin may stimulate immune function
● Diabetes medications — may affect blood sugar levels
● Sedatives and CNS depressants — additive drowsiness

일일 최대 섭취 허용량: No established UL; 5 mg typically considered maximum

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 멜라토닌 help with 노화에 따른 수면 변화?

Based on 5 studies with 24 participants, there is moderate evidence from clinical studies that 멜라토닌 may support 노화에 따른 수면 변화 management. Our evidence grade is B (Good Evidence).

How much 멜라토닌 should I take for 노화에 따른 수면 변화?

Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 멜라토닌?

Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 멜라토닌 and 노화에 따른 수면 변화?

We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 24 total participants. The overall direction of effect is positive.

Related Evidence

멜라토닌 다른 건강 상태에 대한 근거

불면증 A 일주기 리듬 장애 A 시차증(제트래그) A 교대근무 수면장애 A 수면 개시 장애 A

한눈에 보기

총 30명의 참여자를 대상으로 한 3건의 연구(RCT 1건)에 근거합니다. 3건 중 3건의 연구에서 긍정적인 효과가 나타났습니다.

Evidence Strength72%

High confidence

연구 분석

RCT (1)Meta (0)Other (4)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 노화에 따른 수면 변화

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.